FIG 4.

Proportion of participants with cabotegravir at trough and concentrations in follow-up phase above various thresholds by visit. PA-IC₉₀ = 0.166 μg/mL. LLOQ, lower limit of quantitation; PA-IC₉₀, in vitro protein-adjusted concentration resulting in 90% of the maximum inhibition of viral growth for cabotegravir. The first injection was at week 5 and the final injection was at week 33. The week 89 visit was delayed in 12 participants, and therefore, 25/37 participants who completed the week 89 visit were considered within the visit window. The number in parentheses represents the number of participants.